Lb Pharmaceuticals (LBRX) Equity Ratio (2024 - 2026)

Lb Pharmaceuticals' Equity Ratio history runs 3 years deep, the most recent figure standing at 0.96 for Q1 2026.

• In Q1 2026, Equity Ratio changed N/A year-over-year to 0.96; the TTM figure through Mar 2026 stood at 0.96 (changed N/A YoY), while the FY2025 annual figure was 0.96, up 134.15% from the prior year.
• Equity Ratio was 0.96 for Q1 2026 at Lb Pharmaceuticals, roughly flat from 0.96 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.97 in Q3 2025 to a low of 2.82 in Q4 2024.
• Historically, Equity Ratio has averaged 0.02 across 3 years, with a median of 0.96 in 2025.
• Biggest YoY gain for Equity Ratio was 134.15% in 2025; the steepest drop was 134.15% in 2025.
• A 3-year view of Equity Ratio shows it stood at 2.82 in 2024, then soared by 134.15% to 0.96 in 2025, then fell by 0.05% to 0.96 in 2026.
• The last three Equity Ratio figures came in at 0.96 (Q1 2026), 0.96 (Q4 2025), and 0.97 (Q3 2025), per Business Quant data.